查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493276

深奧測試市場規模、佔有率、趨勢分析報告：按類型、按技術、按最終用途、按地區、細分市場預測，2024-2030 年

Esoteric Testing Market Size, Share & Trends Analysis Report By Type (Oncology Testing, Infectious Disease Testing), By Technology (Chemiluminescence Immunoassay), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 115 Pages | 商品交期: 2-10個工作天內

價格

深奧測試市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球深奧測試市場規模將達到479.8億美元，2024年至2030年複合年成長率為11.81%。

推動市場成長的主要因素包括癌症盛行率的上升以及對安全有效檢測的需求不斷成長。根據國際癌症研究機構的報告，2020年有19,292,789名癌症患者，預計2025年將增加至50,550,287名。最常見的癌症是乳癌、大腸癌、肺癌、攝護腺癌和胃癌。

此外，在深奧的DNA測序技術的進步的幫助下，慢性病和感染疾病病率的上升預計將進一步推動整體市場的成長。例如，根據 CDC 的數據，心臟病是美國的首要死因，每 33 秒就有一人死亡。此外，根據美國國家糖尿病統計報告，美國總人口的11.6%患有糖尿病。此類主要感染疾病的高盛行率預計將推動對深奧檢測的需求。

由於高功效和特異性、高訊號強度、良好的精度和高精度等優勢，人們對深奧測試的偏好不斷增加，預計將推動預測期內對進階測試的需求。此外，醫生和患者對用於早期疾病診斷的深奧測試設備的認知不斷增強。這一轉變預計將顯著提高測試採用率並推動市場成長。

此外，由於對預防性醫療保健的偏好和意識不斷提高，醫療保健支出的增加正在推動市場成長。例如，在美國，《平價醫療法案》(ACA) 透過為推薦的預防性服務提供保險計劃，幫助人們獲得並負擔醫療保健費用。此外，增加患者參與疾病管理和轉向實證治療也有助於市場成長。

同樣，這些測試是識別罕見疾病的簡單方法。因此，罕見疾病在人群中患病率的增加預計將推動市場擴張。據美國衛生與公眾服務部稱，美國新增約2,205例西尼羅河病毒感染疾病病例。感染疾病的深奧檢測市場正在不斷成長，因為傳染病的深奧檢測可以輕鬆檢測出這些罕見疾病。政府資助的舉措，例如意識提升宣傳活動、篩檢計劃和特定癌症計劃，預計將增加診斷病例的數量。例如，印度衛生部長癌症患者基金（HMCPF）計劃為貧困癌症患者提供財政支持。預計這將增加對深奧測試的需求並推動區域成長。

市場上經營的主要公司不斷致力於開發新產品，以滿足日益成長的疾病預防和早期診斷的需求。例如，2023 年 7 月，Quest Diagnostics 宣布推出消費者主導的基因測試，其獨特功能包括強大的 NGS 支援服務、訂購和一對一基因測試。此外，領先的公司正專注於地理擴張，以增加其影響力和獲得有效產品的機會。例如，2022 年 6 月，SRL Diagnostics 在印度清奈的Ashok Nagar 開設了參考實驗室。這個佔地 20,000 平方英尺的實驗室每月可以進行 1,000 多項測試，從廣譜測試到未經證實的測試和基因測試。

深奧的測試市場報告亮點

  • 按類型分類，由於深奧檢測在癌症診斷中的突出應用，腫瘤學領域預計將在 2023 年佔據市場主導地位，而基因檢測領域預計在預測期內將以最快的複合年成長率成長。
  • 從技術來看，化學冷光免疫檢測技術領域在2023年佔據市場主導地位。然而，酵素結合免疫吸附檢測法預計將在預測期內顯示出最快的成長。
  • 按最終用途分類，獨立實驗室和參考實驗室部分在 2023 年佔據最大佔有率。然而，預計醫院實驗室在預測期內將出現最快的成長。
  • 由於感染疾病發病率上升、政府對優質醫療保健的支持、高購買力和高效的報銷方案等因素，北美在市場上佔據主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章深奧的測試市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 深奧的測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 深奧的測驗市場：按類型估算和趨勢分析

  • 細分儀表板
  • 全球深奧測試市場波動分析
  • 按類型分類的全球 Esoteric 測試市場展望
  • 腫瘤檢查
  • 傳染病檢查
  • 基因檢測
  • 內分泌檢查
  • 毒性試驗
  • 神經學檢查
  • 其他

第5章 深奧的測試市場：技術預估與趨勢分析

  • 細分儀表板
  • 全球深奧測試市場波動分析
  • 按技術分類的全球深奧測試市場前景
  • 化學冷光免疫檢測
  • 酵素免疫分析法
  • 質譜
  • 即時聚合酵素鏈鎖反應
  • 流式細胞技術
  • 其他

第 6 章 深奧的測試市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球深奧測試市場波動分析
  • 按最終用途分類的全球深奧測試市場展望
  • 醫院實驗室
  • 獨立參考實驗室
  • 其他

第7章 深奧測驗市場：按地區估算及趨勢分析

  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Laboratory Corporation of America Holdings
    • OPKO Health, Inc.
    • Quest Diagnostics Incorporated
    • Sonic Healthcare Limited
    • HU Group Holdings, Inc.
    • Kindstar Globalgene Technology, Inc.
    • Stanford Health Care
    • Mayo Foundation for Medical Education and Research
    • ARUP Laboratories.
    • Athena Esoterix
    • ACM Global Laboratories
    • Healius Limited.
Product Code: GVR-4-68040-272-6

Esoteric Testing Market Growth & Trends:

The global esoteric testing market size is anticipated to reach USD 47.98 billion by 2030, expanding at a CAGR of 11.81% from 2024 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth include rising prevalence of cancer and growing need for safe and effective tests. The International Agency for Research on Cancer reports that 19,292,789 cancer cases were recorded in 2020 and estimates that number will rise to 50,550,287 by 2025. The most frequently reported cancers are breast, colorectal, lung, prostate, and stomach.

Moreover, the rising prevalence of chronic and infectious diseases aided by the advancements in esoteric DNA sequencing technologies is further anticipated to drive overall growth of the market. For instance, according to CDC, heart disease are leading cause of death in the U.S., and accounts for the death of one person every 33 seconds. Furthermore, according to the National Diabetes Statistics Report, 11.6% of the total population in the U.S. suffer from diabetes. Such a high prevalence of major infectious diseases is anticipated to drive the demand for esoteric testing.

The growing preference for esoteric testing, attributed to advantages like high efficacy and specificity, high signal intensity, good precision, and high accuracy, is projected to drive the demand for advanced tests during the forecast period. Furthermore, rising awareness of esoteric testing devices among physicians and patients for early disease diagnosis. This shift is anticipated to substantially boost the adoption of tests, thereby driving market growth.

Moreover, the rising healthcare expenditure aided with rising preference and awareness regarding preventive healthcare is fueling the growth of the market. For example, the Affordable Care Act (ACA) helps in providing accessible and affordable for people in U.S. by providing insurance plans for recommended preventive services. Additionally, the growing patient participation in disease management and the shift towards evidence-based treatment are also contributing to the growth of the market.

Similarly, these tests are a simple way to identify rare diseases. Therefore, the population's increasing incidence of rare diseases is anticipated to support market expansion. As per the U.S. Department of Health and Human Services, around 2,205 new West Nile virus disease cases in the U.S. The esoteric testing market is growing because esoteric tests for infectious diseases can easily detect these rare diseases. Government-sponsored initiatives, including awareness campaigns, screening programs, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, India's Health Minister Cancer Patient Fund (HMCPF) program financially assists deprived cancer patients. This is anticipated to increase demand for esoteric testing and promote regional growth.

Key players operating in the market are constantly focusing on development of novel products to meet the rising demand for preventive and early diseases diagnosis. For instance, in July 2023, Quest Diagnostics announced the launch of consumer-initiated genetic tests with unique feature including robust NGS support services, ordering, and access to one-on-one genetic testing. Moreover, major players are focusing on geographic expansion to enhance their presence and expand access to effective products. For instance, in June 2022, SRL Diagnostics opened a reference laboratory in Ashok Nagar, Chennai, India. The 20,000-square-foot laboratory can perform over one lakh monthly tests, ranging from widespread examinations to unidentified and genetic tests.

Esoteric Testing Market Report Highlights:

  • Based on type, the oncology segment dominated the market in 2023 owing to prominent application of esoteric testing in cancer diagnosis and genetic testing segment is expected to grow at the fastest CAGR over the forecast period
  • Based on technology, the chemiluminescence immunoassay technology segment dominated the market in 2023. However, enzyme-linked immunosorbent assay is anticipated to witness fastest growth over the forecast period
  • Based on end-use, the independent and reference laboratories segment held the largest share in 2023. However, hospital-based laboratories is anticipated to witness fastest growth over the forecast period
  • North America dominated the market owing to factors such as rising incidence of infectious diseases, government support for quality healthcare, high purchasing power, and efficient reimbursement scenario

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of infectious disease
      • 3.2.1.2. Technological advancements in esoteric testing
      • 3.2.1.3. Increasing per capita income
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of skilled healthcare professional in developing countries
      • 3.2.2.2. Stringent regulatory framework
  • 3.3. Esoteric Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Esoteric Testing Market Movement Analysis
  • 4.3. Global Esoteric Testing Market by Type Outlook
  • 4.4. Oncology testing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Infectious disease testing
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Genetic testing
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Endocrinology testing
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Toxicology testing
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Neurology testing
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Esoteric Testing Market Movement Analysis
  • 5.3. Global Esoteric Testing Market by Technology Outlook
  • 5.4. Chemiluminescence immunoassay
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Enzyme-linked immunosorbent assay
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Mass spectrometry
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Real time polymerase chain reaction
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Flow cytometry
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Esoteric Testing Market Movement Analysis
  • 6.3. Global Esoteric Testing Market by End-use Outlook
  • 6.4. Hospital-based laboratories
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.5. Independent and reference laboratories
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Laboratory Corporation of America Holdings
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. OPKO Health, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Quest Diagnostics Incorporated
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sonic Healthcare Limited
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. H.U. Group Holdings, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Kindstar Globalgene Technology, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Stanford Health Care
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mayo Foundation for Medical Education and Research
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. ARUP Laboratories.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Athena Esoterix
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. ACM Global Laboratories
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
      • 8.3.14.3. Product benchmarking
    • 8.3.14. Healius Limited.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 South Korea esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Brazil esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Esoteric Testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Esoteric testing market: market outlook
  • Fig. 14 Esoteric testing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Esoteric testing market driver impact
  • Fig. 20 Esoteric testing market restraint impact
  • Fig. 21 Esoteric testing market strategic initiatives analysis
  • Fig. 22 Esoteric testing market: Type movement analysis
  • Fig. 23 Esoteric testing market: Type outlook and key takeaways
  • Fig. 24 Oncology testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Infectious disease testing estimates and forecast, 2018 - 2030
  • Fig. 26 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 27 Endocrinology testing estimates and forecast, 2018 - 2030
  • Fig. 28 Toxicology testing market estimates and forecast, 2018 - 2030
  • Fig. 29 Neurology testing market estimates and forecast, 2018 - 2030
  • Fig. 30 Others estimates and forecast, 2018 - 2030
  • Fig. 31 Esoteric testing Market: Technology movement Analysis
  • Fig. 32 Esoteric testing market: Technology outlook and key takeaways
  • Fig. 33 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 34 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 35 Enzyme-linked immunosorbent assay market estimates and forecasts, 2018 - 2030
  • Fig. 36 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
  • Fig. 37 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030
  • Fig. 39 Esoteric testing market: End use movement analysis
  • Fig. 40 Esoteric testing market: End use outlook and key takeaways
  • Fig. 41 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 42 Independent and reference laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030
  • Fig. 44 Global esoteric testing market: Regional movement analysis
  • Fig. 45 Global esoteric testing market: Regional outlook and key takeaways
  • Fig. 46 Global esoteric testing market share and leading players
  • Fig. 47 North America market share and leading players
  • Fig. 48 Europe market share and leading players
  • Fig. 49 Asia Pacific market share and leading players
  • Fig. 50 Latin America market share and leading players
  • Fig. 51 Middle East & Africa market share and leading players
  • Fig. 52 North America: SWOT
  • Fig. 53 Europe SWOT
  • Fig. 54 Asia Pacific SWOT
  • Fig. 55 Latin America SWOT
  • Fig. 56 MEA SWOT
  • Fig. 57 North America, by country
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecasts, 2018 - 2030
  • Fig. 60 U.S. Key Country Dynamics
  • Fig. 61 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 62 Canada Key Country Dynamics
  • Fig. 63 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 66 UK Key Country Dynamics
  • Fig. 67 UK market estimates and forecasts, 2018 - 2030
  • Fig. 68 Germany Key Country Dynamics
  • Fig. 69 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 70 France Key Country Dynamics
  • Fig. 71 France market estimates and forecasts, 2018 - 2030
  • Fig. 72 Italy Key Country Dynamics
  • Fig. 73 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 74 Spain Key Country Dynamics
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 76 Denmark Key Country Dynamics
  • Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 78 Sweden Key Country Dynamics
  • Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 80 Norway Key Country Dynamics
  • Fig. 81 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 84 China Key Country Dynamics
  • Fig. 85 China market estimates and forecasts, 2018 - 2030
  • Fig. 86 Japan Key Country Dynamics
  • Fig. 87 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 88 India Key Country Dynamics
  • Fig. 89 India market estimates and forecasts, 2018 - 2030
  • Fig. 90 Thailand Key Country Dynamics
  • Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 92 South Korea Key Country Dynamics
  • Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 94 Australia Key Country Dynamics
  • Fig. 95 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 98 Brazil Key Country Dynamics
  • Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 100 Mexico Key Country Dynamics
  • Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 102 Argentina Key Country Dynamics
  • Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 104 Middle East and Africa
  • Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 106 South Africa Key Country Dynamics
  • Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 Saudi Arabia Key Country Dynamics
  • Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 110 UAE Key Country Dynamics
  • Fig. 111 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 112 Kuwait Key Country Dynamics
  • Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 114 Market share of key market players- esoteric testing market